EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Cell differentiation-related signaling pathways in hepatocellular carcinoma metastasis

Ze Xiang, Jiarui Li, Yunyang Xu, Chenhao Xu, Shusen Zheng, Jian Chen, Xuyong Wei, Xiao Xu

Cancer Letters · 2025-09 · 627 · 217846

DOI: 10.1016/j.canlet.2025.217846 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Cancer Letters, 2025-09. Verfasst von Ze Xiang und 7 weiteren Autor:innen. Beteiligte Einrichtung: Zhejiang University School of Medicine, Hangzhou, 310058, China. Hauptthemen laut MEDLINE: Carcinoma, Hepatocellular, Liver Neoplasms, Signal Transduction, Cell Differentiation. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 358 Literaturangaben. Gefördert von: National Natural Science Foundation of China, National Key Research and Development Program of China, Major Research Plan of the National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Primary liver cancer is the third leading cause of cancer-related deaths worldwide, with persistently high incidence and mortality rates. Hepatocellular carcinoma (HCC), the most common type of primary liver cancer, has a complex pathogenesis. Moreover, due to the low rate of early diagnosis and limited treatment options, the prognosis for HCC patients is poor, with a median overall survival of approximately one year for advanced-stage HCC. Cancer metastasis is one of the main reasons for HCC-related deaths. During the metastatic process, tumor cells undergo a series of complex biological changes, including epithelial-mesenchymal transition, extracellular matrix remodeling, angiogenesis, and resistance to anoikis, which are key steps. These changes promote the invasion and migration of tumor cells and are central mechanisms of cancer progression. In the metastatic process of HCC, signaling pathways that regulate cell proliferation, differentiation, and apoptosis, such as Hippo-YAP/TAZ, Wnt/β-catenin, Notch, Hedgehog and JAK/STAT, become dysregulated and play a promoting role in the aggressive growth and distant migration of HCC cells. Treatment strategies targeting these pathways are currently being developed. These new agents, being more targeted, may have better tolerability and fewer adverse effects. This review focuses on the role of these key signaling pathways in the metastatic process of HCC and summarizes the treatment strategies targeting these pathways.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, HepatocellularLiver NeoplasmsSignal TransductionCell DifferentiationHumansAnimalsEpithelial-Mesenchymal TransitionCell MovementNeoplasm Metastasis

Stichwörter der Autor:innen

Cell differentiationHepatocellular carcinomaMetastasisSignaling pathwaysTreatment strategies

Autor:innen und Institutionen

  • Zhejiang University School of Medicine, Hangzhou, 310058, China.
  • Department of Hepatobiliary and Pancreatic Surgery, Shulan (Hangzhou) Hospital, Zhejiang Shuren University School of Medicine, Hangzhou, 310022, China.
  • Department of Hepatobiliary and Pancreatic Surgery, Affiliated Hangzhou First People's Hospital, School of Medicine, Westlake University, Hangzhou, 310006, China. Electronic address: zju_chenjian@zju.edu.cn.
  • Department of Hepatobiliary and Pancreatic Surgery, Affiliated Hangzhou First People's Hospital, School of Medicine, Westlake University, Hangzhou, 310006, China. Electronic address: 1315009@zju.edu.cn.
  • School of Clinical Medicine, Hangzhou Medical College, Hangzhou, 310059, China; Institute of Translational Medicine, Zhejiang University, Hangzhou, 310009, China. Electronic address: zjxu@zju.edu.cn.

Förderung

  • National Natural Science Foundation of China
  • National Key Research and Development Program of China
  • Major Research Plan of the National Natural Science Foundation of China
  • Zhejiang Provincial Natural Science Foundation of China
  • Natural Science Foundation of Zhejiang Province

Zitieren

APA

Xiang, Z., Li, J., Xu, Y., Xu, C., Zheng, S., Chen, J., Wei, X., & Xu, X. (2025). Cell differentiation-related signaling pathways in hepatocellular carcinoma metastasis. Cancer Letters, 627, 217846. https://doi.org/10.1016/j.canlet.2025.217846

Vancouver

Xiang Z, Li J, Xu Y, Xu C, Zheng S, Chen J, et al. Cell differentiation-related signaling pathways in hepatocellular carcinoma metastasis. Cancer Letters. 2025;627:217846. doi:10.1016/j.canlet.2025.217846

BibTeX
@article{Xiang2025,
  author = {Xiang, Ze and Li, Jiarui and Xu, Yunyang and Xu, Chenhao and Zheng, Shusen and Chen, Jian and Wei, Xuyong and Xu, Xiao},
  title = {Cell differentiation-related signaling pathways in hepatocellular carcinoma metastasis},
  journal = {Cancer Letters},
  year = {2025},
  volume = {627},
  pages = {217846},
  doi = {10.1016/j.canlet.2025.217846}
}
Kostenlos starten →